The Immunology Quality Assessment Program (IQA) is a flexible resource, designed to help investigators assess the quality of immunologic assays performed on subjects enrolled in NIAID-sponsored or collaborative HIV/AIDS studies, and to help with standardization and implementation of new immunologic assays in such studies. The IQA facilitates research to identify and quantify the sources of variability (intra-assay, intra- subject) in immunologic assays used for the monitoring of subjects in research studies (e.g. clinical trials, epidemiologic cohorts) so that this information can be used to improve study design and analysis. Specifically, the IQA Contractor obtains, characterizes, documents, stores and distributes coded quality control materials, such as whole blood, plasma and cells from HIV positive and negative donors with known immunological and virological profiles, and periodically provides these materials to designated laboratories for the purpose of monitoring and evaluating their ability to perform immunological measurements. When appropriate, investigators formulate criteria for acceptable assay performance and laboratories are being evaluated and graded. In addition, quality control materials and other reagents are provided to designated laboratories in order to facilitate comparative evaluations of instruments, reagents, and methods, and for the purpose of identifying and quantifying sources of variability in various immunological assays. Statistical analyses are performed on data received from participating laboratories and results are shared with investigators.

Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Medicine & Dentistry of NJ
Schools of Medicine
United States
Zip Code
Garcia, Ambrosia; Keinonen, Sarah; Sanchez, Ana M et al. (2014) Leukopak PBMC sample processing for preparing quality control material to support proficiency testing programs. J Immunol Methods 409:99-106
Richards, Adam J; Staats, Janet; Enzor, Jennifer et al. (2014) Setting objective thresholds for rare event detection in flow cytometry. J Immunol Methods 409:54-61
Hultin, Lance E; Chow, Marianne; Jamieson, Beth D et al. (2010) Comparison of interlaboratory variation in absolute T-cell counts by single-platform and optimized dual-platform methods. Cytometry B Clin Cytom 78:194-200
Weinberg, Adriana; Song, Lin-Ye; Wilkening, Cynthia et al. (2009) Optimization and limitations of use of cryopreserved peripheral blood mononuclear cells for functional and phenotypic T-cell characterization. Clin Vaccine Immunol 16:1176-86
Denny, Thomas N; Gelman, Rebecca; Bergeron, Michele et al. (2008) A North American multilaboratory study of CD4 counts using flow cytometric panLeukogating (PLG): a NIAID-DAIDS Immunology Quality Assessment Program Study. Cytometry B Clin Cytom 74 Suppl 1:S52-64
Weinberg, Adriana; Louzao, Raul; Mussi-Pinhata, Marisa M et al. (2007) Quality assurance program for peripheral blood mononuclear cell cryopreservation. Clin Vaccine Immunol 14:1242-4
Hultin, Lance E; Menendez, Frederick A; Hultin, Patricia M et al. (2007) Assessing immunophenotyping performance: proficiency-validation for adopting improved flow cytometry methods. Cytometry B Clin Cytom 72:249-55
Schnizlein-Bick, Carol T; Mandy, Francis F; O'Gorman, Maurice R G et al. (2002) Use of CD45 gating in three and four-color flow cytometric immunophenotyping: guideline from the National Institute of Allergy and Infectious Diseases, Division of AIDS. Cytometry 50:46-52
Schmitz, John L; Denny, Thomas N; Garcia, Ambrosia et al. (2002) Comparison of human immunodeficiency virus antigens as stimulants for lymphocyte proliferation assays. Clin Diagn Lab Immunol 9:525-9